Michael Barnett

Contact Information
Gordon and Leslie Diamond Health Care Centre
10th Floor, 2775 Laurel St
Vancouver, BC, Canada
Tel 1-604-875-4863
Fax 1-604-875-4763
mbarnett@bccancer.bc.ca

Current Positions

  • Clinical Professor, Division Head/Associate Head, Hematology/Bone Marrow Transplant Medicine, Medicine
  • Vancouver Coastal Health
  • Associate Member, BC Cancer Agency

Research Interests

Dr. Barnett spends his professional time treating patients with hematological malignancies and has a particular interest in the myeloid leukemias.

Publications

  1. Abou Mourad YR, Bhargava R, Bruyère H, Gillian T, Barnett MJ, Forrest DL, Nevill TJ, Toze CL, Nantel SH, Shepherd JD. Clin Lymphoma Myeloma Leuk. Normal Karyotype CALLA-Positive Adult Pre-B ALL: Dismal Outcome With Chemotherapy for Patients With Loss/Gain of ABL1 and/or BCR FISH Signals. Clin Lymphoma Myeloma Leuk. 2013 Jun;13(3):281-6.
  2. Abou Mourad YR, Bhargava R, Bruyère H, Gillian T, Barnett MJ, Forrest DL, Nevill TJ, Toze CL, Nantel SH, Shepherd JD. Clin Lymphoma Myeloma Leuk. 2012 Oct 23.  Normal Karyotype CALLA-Positive Adult Pre-B ALL: Dismal Outcome With Chemotherapy for Patients With Loss/Gain of ABL1 and/or BCR FISH Signals.
  3. Toze CL, Dalal CB, Nevill TJ, Gillan TL, Abou Mourad YR, Barnett MJ, Broady RC, Forrest DL, Hogge DE, Nantel SH, Power MM, Song KW, Sutherland HJ, Smith CA, Narayanan S, Young SS, Connors JM, Shepherd JD. Allogeneic haematopoietic stem cell transplantation for chronic lymphocytic leukaemia: outcome in a 20-year cohort. Br J Haematol. 2012 Jul;158(2):174-85.
  4. Bödör C, Renneville A, Smith M, Charazac A, Iqbal S, Etancelin P, Cavenagh J, Barnett MJ, Kramarzova K, Krishnan B, Matolcsy A, Preudhomme C, Fitzgibbon J, Owen C. Germ-line GATA2 p.THR354MET mutation in familial myelodysplastic syndrome with acquired monosomy 7 and ASXL1 mutation demonstrating rapid onset and poor survival. Haematologica. 2012 Jan 22. [Epub ahead of print]
  5. Tantiworawit A, Power MM, Barnett MJ, Hogge DE, Nantel SH, Nevill TJ, Shepherd JD, Song KW, Sutherland HJ, Toze CL, Abou-Mourad YR, Narayanan S, Broady RC, Forrest DL. Long-term Follow-up of Patients with Chronic Myeloid Leukemia in Chronic Phase Developing Sudden Blast Phase on Imatinib Therapy. Leuk Lymphoma. 2011 Dec 22. [Epub ahead of print]
  6. Bacon LC, Barnett MJ, Abou Mourad YR. Vincristine-induced vocal cord paralysis in a patient with acute lymphoblastic leukemia. Ann Hematol. 2011 Oct 6. [Epub ahead of print]
  7. Sakoda LC, Loomis MM, Doherty JA, Neuhouser ML, Barnett MJ, Thornquist MD, Weiss NS, Goodman GE, Chen C. Chromosome 15q24-25.1 variants, diet, and lung cancer susceptibility in cigarette smokers. Cancer Causes Control. 2011 Mar;22(3):449-61. Epub 2011 Jan 13
  8. Venner CP, Connors JM, Sutherland HJ, Shepherd JD, Hamata L, Mourad YA, Barnett MJ, Broady R, Forrest DL, Hogge DE, Nantel SH, Narayanan S, Nevill TJ, Nitta J, Power MM, Toze CL, Smith CA, Song KW. Novel agents improve survival of transplant patients with multiple myeloma including those with high-risk disease defined by early relapse (<12 months). Leuk Lymphoma. 2011 Jan;52(1):34-41. Epub 2010 Dec 6.
  9. Seftel MD, Paulson K, Doocey R, Song K, Czaykowski P, Coppin C, Forrest D, Hogge D, Kollmansberger C, Smith CL, Shepherd JD, Toze CL, Murray N, Sutherland H, Nantel S, Nevill TJ, Barnett MJ. Long-term follow-up of patients undergoing auto-SCT for advanced germ cell tumour: a multicentre cohort study. Bone Marrow Transplant. 2010 Nov 1. [Epub ahead of print]
  10. Wright MP, Shepherd JD, Barnett MJ, Nantel SH, Sutherland HJ, Toze CL, Hogge DE, Nevill TJ, Song KW, Abou Mourad YR, Narayanan S, Power MM, Smith CA, Forrest DL. Response to tyrosine kinase inhibitor therapy in patients with chronic myelogenous leukemia relapsing in chronic and advanced phase following allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2010 May;16(5):639-46. Epub 2010 Feb 4.
  11. Abou-Mourad YR, Lau BC, Barnett MJ, Forrest DL, Hogge DE, Nantel SH, Nevill TJ, Shepherd JD, Smith CA, Song KW, Sutherland HJ, Toze CL, Lavoie JC. Long-term outcome after allo-SCT: close follow-up on a large cohort treated with myeloablative regimens. Bone Marrow Transplant. 2010 Feb;45(2):295-302. Epub 2009 Jul 13.

Education

M.D., FRCPC, FRCP, FRCPath

Comments are closed, but trackbacks and pingbacks are open.